Evidence map›Paper›PMID 23397042›Full record

ArticleEvolutionary applications2013

Applying ecological and evolutionary theory to cancer: a long and winding road.

Frédéric Thomas, Daniel Fisher, Philippe Fort, Jean-Pierre Marie, Simon Daoust, Benjamin Roche, Christoph Grunau, Céline Cosseau, Guillaume Mitta, Stephen Baghdiguian and 28 more

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. CancerFrontiers in immunology · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer.Cold Spring Harbor perspectives in medicine · 2017
    Review
  18. PhyloOncology: Understanding cancer through phylogenetic analysis.Biochimica et biophysica acta. Reviews on cancer · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 13 institutions in 2 countries.

Frédéric ThomasMIVEGEC (UMR CNRS/IRD/UM1) 5290 Montpellier Cedex 5, France ; CREEC Montpellier Cedex 5, France.
Daniel Fisher
Philippe Fort
Jean-Pierre Marie
Simon Daoust
Benjamin Roche
Christoph Grunau
Céline Cosseau
Guillaume Mitta
Stephen Baghdiguian
François Rousset
Patrice Lassus
Eric Assenat
Damien Grégoire
Dorothée Missé
Alexander Lorz
Frédérique Billy
William Vainchenker
François Delhommeau
Serge Koscielny
Raphael Itzykson
Ruoping Tang
Fanny Fava
Annabelle Ballesta
Thomas Lepoutre
Liliana Krasinska
Vjekoslav Dulic
Peggy Raynaud
Philippe Blache
Corinne Quittau-Prevostel
Emmanuel Vignal
Hélène Trauchessec
Benoit Perthame
Jean Clairambault
Vitali Volpert
Eric Solary
Urszula Hibner
Michael E Hochberg
Centre National de la Recherche Scientifique · FRUniversité de Montpellier · FRSorbonne Université · FRInstitut Gustave Roussy · FRMaladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle · FRCentre de Recherche en Biologie cellulaire de Montpellier · FRÉcologie et Biologie des Interactions · FRHôpital Saint-Antoine · FRInserm · FRInstitut de Recherche pour le Développement · FRInstitut des Sciences de l'Evolution de Montpellier · FRLaboratoire Jacques-Louis Lions · FRUnité de Modélisation Mathématique et Informatique des Systèmes Complexes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the mid 1970s, cancer has been described as a process of Darwinian evolution, with somatic cellular selection and evolution being the fundamental processes leading to malignancy and its many manifestations (neoangiogenesis, evasion of the immune system, metastasis, and resistance to therapies). Historically, little attention has been placed on applications of evolutionary biology to understanding and controlling neoplastic progression and to prevent therapeutic failures. This is now beginning to change, and there is a growing international interest in the interface between cancer and evolutionary biology. The objective of this introduction is first to describe the basic ideas and concepts linking evolutionary biology to cancer. We then present four major fronts where the evolutionary perspective is most developed, namely laboratory and clinical models, mathematical models, databases, and techniques and assays. Finally, we discuss several of the most promising challenges and future prospects in this interdisciplinary research direction in the war against cancer.

Indexed as

cancer, disease biologyevolutionary medicineevolutionary theory

Identifiers

PMID23397042
PMCPMC3567465
OpenAlexW2085755609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.